[Other] Abbreviated or standard antiplatelet therapy after PCI in HBR patients with chronic kidney disease: a prespecified analysis from the MASTER DAPT trial

OliviaWang Post time 1 hour(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-07-18 10:59
Reward20points

journalㄩEuroIntervention

AuthorsㄩAntonio Landi; Felix Mahfoud; Enrico Frigoli; Konstantina Chalkou; Dik Heg; Rajpal K. Abhaichand; Atul Damodar Abhyankar; Emanuele Barbato; Farzin Beygui; Peter W. Danse; Ali Garachemani; Bruno Garc赤a del Blanco; Kurt Huber; Ren谷 Koning; Neville Kukreja; Christophe Piot; Nguyen Ngoc Quang; Ashok Tirouvanziam; Mathieu Valla; Pieter C. Smits; Marco Valgimigli; on behalf of the MASTER DAPT investigators

Published dateㄩ--

DOIㄩ10.4244/eij-d-25-00566

Article linkㄩhttps://doi.org/10.4244/eij-d-25-00566

Article SourceㄩEuropa Digital & Publishing


Remarkㄩ
Reply

Use magic Donate Report

All Reply0 Show all posts

Reply

You have to log in before you can reply Login | Register

Points Rules

Return to the list